Evaluation of memantine for the treatment of Alzheimer’s disease

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.4, Iss.12, 2003-12, pp. : 2305-2313

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is memantine a breakthrough in the treatment of moderate-to-severe Alzheimer’s disease?

By Doggrell Sheila

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 10, 2003-10 ,pp. : 1857-1860

Informa Healthcare

Access to resources Recommend Favorite

Pharmacoeconomics of Cholinesterase Inhibitors in the Treatment of Alzheimers Disease

By Jönsson L.

PharmacoEconomics, Vol. 21, Iss. 14, 2003-01 ,pp. : 1025-1037

Adis International

Access to resources Recommend Favorite

The pharmacology of donepezil: a new treatment for Alzheimer’s disease

By Wilkinson D.G.

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 1, 1999-11 ,pp. : 121-135

Informa Healthcare

Access to resources Recommend Favorite

Emerging strategies for the treatment of Alzheimer’s disease at the Millennium

By Emmerling M.R. Spiegel K. D Hall E. LeVine H. Walker L.C. Schwarz R.D. Gracon S.

Expert Opinion on Emerging Drugs, Vol. 4, Iss. 1, 1999-01 ,pp. : 35-86

Informa Healthcare

Access to resources Recommend Favorite

Future directions in the treatment of Alzheimer’s disease

By Bullock Roger

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 4, 2004-04 ,pp. : 303-314

Informa Healthcare

Access to resources Recommend Favorite